Unlike older GLP-1 therapies that target a single receptor, Tirzepatide acts on two GLP-1 and GIP making it one of the most effective weight-loss medications studied
The 12 mg dose produced the largest mean weight loss, about 24.2% at 48 weeks, in the Phase 2 trial (Jastreboff et al., 2023)
A Chicago physicians evidence-based guide to hormones, metabolism, and the integrative solutions most doctors never mention
Personalized programs that allow you to discuss your gut health and side effects with a specialist
This is often accompanied by a phenomenon known as Semaglutide face, where facial appearance is altered, with hollowing and skin laxity becoming evident
When you combine the sympathomimetic stimulation of phentermine with the incretin-mediated heart rate increase from tirzepatide, monitoring becomes absolutely essential